Skip to main content
OpenTrials

Clinical trial condition

Leukemia

Explore clinical trials studying Leukemia. Study availability and eligibility vary by location and protocol.

4,408 public trials 1,033 recruiting studies
Refine in advanced search Browse all conditions

Leukemia trial results

Recruiting

First-in-human (FIH) Trial of GEN3018 in Relapsed or Refractory (R/R) Acute Myeloid Leukemia (AML) or Higher-risk Myelodysplastic Syndrome (HR-MDS)

NCT07384715

Conditions
Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +8 more
Locations
  • Aarhus Universitetshospital - Skejby Aarhus, Denmark
  • Copenhagen Rigshospitalet Copenhagen, Denmark
  • Hospital Universitari Vall d'Hebron Barcelona, Spain
  • Hospital Clínic de Barcelona Barcelona, Spain
View Trial Details
Recruiting

A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With Filgrastim as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With High-Risk Acute Myeloid Leukemia

NCT07012044

Conditions
Acute Myeloid Leukemia Post Cytotoxic Therapy, Hematologic Diseases, Hemic and Lymphatic Diseases, +7 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Riley Hospital for Children Indianapolis, Indiana, United States
  • C S Mott Children's Hospital Ann Arbor, Michigan, United States
  • University of Minnesota/Masonic Cancer Center Minneapolis, Minnesota, United States
View Trial Details
Recruiting

A Long-term Extension Study of PCI-32765 (Ibrutinib)

NCT01804686

Conditions
Blood Protein Disorders, Bronchial Diseases, Bronchiolitis, +43 more
Locations
  • City of Hope Cancer Center Duarte, California, United States
  • University of California San Diego Medical Center La Jolla, California, United States
  • University of California Los Angeles Los Angeles, California, United States
  • St. Joseph Hospital Center for Cancer Prevention and Treatment Orange, California, United States
View all 175 locations
View Trial Details
Recruiting

Second STOP After Pioglitazone Priming in CML Patients

NCT02889003

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia (CML), +11 more
Locations
  • Centre Hospitalier de Versailles Le Chesnay, France
  • Hôpital Bicêtre Le Kremlin-Bicêtre, France
  • CHU Lyon Lyon, France
  • CHU de Nantes Nantes, France
View Trial Details
Recruiting

EWALL-PH OBSERVARTORY 2022

NCT07684131

Conditions
Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations
  • Groupe hospitalier sud Amiens, France
  • CHU Angers Angers, France
  • CH de la cote basque Bayonne, France
  • CHU Bordeaux Bordeaux, France
View all 23 locations
View Trial Details
Recruiting

A Decisional Intervention for Older Adults With Acute Myeloid Leukemia and Their Caregivers

NCT06697600

Conditions
Cancer, Hematologic Diseases, Hemic and Lymphatic Diseases, +7 more
Locations
  • University of Alabama at Birmingham, Division of Hematology and Oncology Birmingham, Alabama, United States
  • University of Rochester Medical Center Rochester, New York, United States
  • University of North Carolina Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States
  • Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Section of Hematology/Oncology Winston-Salem, North Carolina, United States
View Trial Details
Recruiting

Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

NCT03874052

Conditions
Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations
  • Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
  • OHSU Knight Cancer Institute Portland, Oregon, United States
  • UT Southwestern/Simmons Cancer Center-Dallas Dallas, Texas, United States
View Trial Details

Related conditions